Riedel, Richard F.
Meadows, Kellen L.
Lee, Paula H.
Morse, Michael A.
Uronis, Hope E.
Blobe, Gerard C.
George, Daniel J.
Crawford, Jeffrey
Niedzwiecki, Donna
Rushing, Christel N.
Arrowood, Christy C.
Hurwitz, Herbert I.
Funding for this research was provided by:
Threshold Pharmaceuticals, Inc.
National Comprehensive Cancer Network (NCCN) Oncology Research Program
Novartis Pharmaceuticals Corporation (US)